Seeking A Meeting? CDER Wants Patient Advocacy Groups To Go Online
Executive Summary
Web portal makes it easier for non-industry stakeholders to request meetings on development and safety matters but might sow confusion for some patient groups, particularly when it comes to externally led patient-focused drug development meetings.
You may also be interested in...
US FDA Sets 'Low Bar' For Meetings With Patients
New request system is intended to boost FDA transparency, allow patients to more easily gain access to agency staff.
From Listening To Advising: The Maturation Of US FDA's Patient-Focused Drug Development Program
With the disease-area meetings required under PDUFA V now behind it, FDA is turning its attention to guiding sponsors and advocacy groups on how to systematically collect patient experience data for use in drug development and regulatory decision-making. At least two guidance documents and a new data repository are on tap for 2018.
US FDA's Patient Affairs Office Is An Office … In Spirit
Rachel Sherman says agency is creating patient affairs staff, but will not undergo reorganization to create an official office.